Closed · RFA-CA-16-501 · CFDA 93.395 · Discretionary

Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1)

Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.

up to $3M
Award range
Closed
Status
March 10, 2017
Close date
-
Expected awards

The verdict

Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1) is a closed discretionary listing from National Institutes of Health that offered Up to $3,000,000. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.

up to $3M
award range
Closed
application status
93.395
CFDA program
12,419
other opportunities from National Institutes of Health

Archived opportunity record

Limited Competition: Cancer Immunotherapy Tri… is closed (last close March 10, 2017). The parent program page for CFDA 93.395 is the reliable place to catch re-announcements. National Institutes of Health still indexes 12,419 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed March 10, 2017

Posted Nov 25 Closes Mar 10

Est. Total Funding

$4,000,000

Instrument

Cooperative Agreement

Description

The purpose of this limited Funding Opportunity Announcement (FOA) is to support the infrastructure to design and conduct multi-institutional Phase I and early Phase II clinical immunotherapy trials for cancer patients, using novel immunomodulatory agents. To realize these goals, the FOA will continue to support the research activities of the Cancer Immunotherapy Trials Network (CITN).

Campus–civic applicant bridge · 4 doors

Limited Competition: Cancer Immunotherapy Tri… bridges educational institutions with civic applicant types (4 doors: Public / state-controlled institutions of higher education; Nonprofits with 501(c)(3) status (other than IHEs); Nonprofits without 501(c)(3) status (other than IHEs); Private institutions of higher education). Expect campus and public/nonprofit operators in the same printed set. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity codes span Education · Health (ED;HL). Only 15 other National Institutes of Health listings share this exact eligibility-code string (0% of 12,420).

Code 06
Public / state-controlled institutions of higher education
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

What to do next

Limited Competition: Cancer Immunotherapy Tri… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.395 may publish future NOFOs under the same assistance listing. Open program
  • Cancer Treatment Research indexes 60 Grants.gov listings in this extract. Program profile
  • National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants